(Q300989)

reactant

1 reference

1 reference

L-dopa metabolic process

participant

1 reference

L-dopa biosynthetic process

product

1 reference

1 reference

cellular response to L-dopa

reactant

1 reference

imported from Wikimedia project

has use

medication

0 references

chemical structure

3,4-Dihydroxy-L-phenylalanin (Levodopa).svg
512 × 258; 4 KB

1 reference

German Wikipedia

image of molecular model or crystal lattice model

Levodopa 3D ball.png
2,000 × 1,499; 481 KB

depicts

ball-and-stick model

0 references

L-DOPA-from-xtal-view-1-3D-sf.png
2,037 × 2,277; 579 KB

depicts

space-filling model

0 references

mass

197.069 dalton

1 reference

levodopa (English)

19 October 2016

1 reference

1 reference

1 reference

ChEBI release 2021-03-01

chemical formula

C₉H₁₁NO₄

1 reference

levodopa (English)

19 November 2016

C1=CC(=C(C=C1CC(C(=O)O)N)O)O

1 reference

levodopa (English)

19 November 2016

C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O

1 reference

levodopa (English)

19 November 2016

3.5 gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N04BA01

World Health Organisation international non-proprietary name

levodopa (English)

2 references

The determination of catecholamines inCrataegus oxyacantha L. Flowers and leaves by high pressure liquid chromatography-electrochemical detection

L-dopa (English)

19 October 2016

Recommended INN: List 9

1969

1 reference

Mucuna holtonii

1 reference

Seeds as sources of L-Dopa

Mucuna urens

1 reference

Seeds as sources of L-Dopa

Amanita muscaria

1 reference

Characterization of a tyrosinase from Amanita muscaria involved in betalain biosynthesis

Ascophyllum nodosum

1 reference

L-3,4-Dihydroxyphenylalanine-3-Sulfate From the Brown Alga, Ascophyllum nodosum

Astragalus hamosus

1 reference

Constituents of Astragalus membranaceus

Crataegus oxyacantha L. (1753)

1 reference

The determination of catecholamines inCrataegus oxyacantha L. Flowers and leaves by high pressure liquid chromatography-electrochemical detection

Mucuna birdwoodiana

1 reference

Determination of l-Dopa Content and Other Significant Nitrogenous Compounds in the Seeds of Seven Mucuna and Stizolobium Species in China

Mucuna interrupta

1 reference

Determination of l-Dopa Content and Other Significant Nitrogenous Compounds in the Seeds of Seven Mucuna and Stizolobium Species in China

Mucuna macrocarpa

1 reference

Determination of l-Dopa Content and Other Significant Nitrogenous Compounds in the Seeds of Seven Mucuna and Stizolobium Species in China

Mucuna lamellata

1 reference

Determination of l-Dopa Content and Other Significant Nitrogenous Compounds in the Seeds of Seven Mucuna and Stizolobium Species in China

Mucuna sempervirens

1 reference

Determination of l-Dopa Content and Other Significant Nitrogenous Compounds in the Seeds of Seven Mucuna and Stizolobium Species in China

Portulaca grandiflora

1 reference

Catecholamine Biosynthesis Dependent on the Dark in Betacyanin-forming Portulaca Callus

Stemonitis herbatica

1 reference

Production of DL-DOPA from acellular slime-mould Stemonitis herbatica

Homo sapiens

1 reference

A community-driven global reconstruction of human metabolism.

mealworm beetle

1 reference

Zum Tyrosinstoffwechsel der Insekten, XVII. Der Tyrosinstoffwechsel vonTenebrio molitorundDrosophila melanogaster

Mucuna pruriens var. utilis

1 reference

Seeds as sources of L-Dopa

Mucuna pruriens

10 references

Mucuna pruriens: improvement of the biotechnological production of the anti-Parkinson drug L-dopa by plant cell selection

Alkaloidal constituents of Mucuna pruriens seeds

Mucuna pruriens proves more effective thanl-DOPA in Parkinson's disease animal model

Determination of l-Dopa Content and Other Significant Nitrogenous Compounds in the Seeds of Seven Mucuna and Stizolobium Species in China

Production of L-DOPA by cell suspension cultures of Mucuna pruriens

Occurrence of L-DOPA and dopamine in plants and cell cultures ofMucuna pruriens and effects of 2,4-d and NaCl on these compounds

L-3,4-dihydroxyphenylalanine as an allelochemical candidate from Mucuna pruriens (L). DC. var. utilis.

Studies on chemical composition and antinutritional factors in three germplasm seed materials of the tribal pulse, Mucuna pruriens (L.) DC

Alkaloidal Constituents of Mucuna pruriens Seeds.

Allelopathy of Velvetbean: Determination and Identification of L-DOPA as a Candidate of Allelopathic Substances

Musa cavendishii

1 reference

High content of dopamine, a strong antioxidant, in Cavendish banana

Oryza sativa

1 reference

Simultaneous determination of the main metabolites in rice leaves using capillary electrophoresis mass spectrometry and capillary electrophoresis diode array detection

Crataegus laevigata

1 reference

The determination of catecholamines inCrataegus oxyacantha L. Flowers and leaves by high pressure liquid chromatography-electrochemical detection

broad bean

4 references

The identification of gibberellins in immature seeds of Vicia faba, and some chemotaxonomic considerations

UHPLC-ESI-QTOF-MS-based metabolic profiling of Vicia faba L. (Fabaceae) seeds as a key strategy for characterization in foodomics

Fast responses of metabolites in Vicia faba L. to moderate NaCl stress

Kaempferol 3-O-Galactoside, 7-O-Rhamnoside is the Major Green Fluorescing Compound in the Epidermis of Vicia faba

medical condition treated

Parkinson's disease

start time

10 June 2003

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/46627O600J

http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021485s20lbl.pdf

significant drug interaction

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methyldopa

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rasagiline

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

G protein-coupled receptor 143

agonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

3639

Australian pregnancy category B3

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/LevodopaCarbodopa

20 July 2017

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D007980

15 March 2018

developmental toxicant

start time

29 January 1999

1 reference

California Proposition 65 list of chemicals

17 March 2020

https://oehha.ca.gov/chemicals/levodopa

MCN code

2922.50.31

0 references

3003.90.45

0 references

Commons category

Levodopa

0 references

Identifiers

InChI

InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1

1 reference

levodopa (English)

19 November 2016

1 reference

levodopa (English)

19 November 2016

2 references

levodopa (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=59-92-7

9 April 2021

1 reference

Levodopa (English)

19 November 2016

2 references

levodopa (English)

19 November 2016

6971033

1 reference

Reaxys registry number

2215169

1 reference

L-dopa (English)

19 October 2016

6060047

1 reference

L-dopa (English)

19 October 2016

365846

0 references

1 reference

LEVODOPA (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Osaka_Univ-OUF00206

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-RIKEN-PR010128

0 references

MSBNK-RIKEN-PR100091

0 references

MSBNK-RIKEN-PR100092

0 references

MSBNK-Kazusa-KZ000173

0 references

SPLASH

splash10-0f6t-0911000000-796795c7db2b08bebd65

0 references

splash10-001i-0900000000-2c310034a1a871502b4c

0 references

splash10-0007-0970100000-0f747f49b6021ce91283

0 references

splash10-001i-0900000000-2183a68f58b951f3f1c7

0 references

splash10-0002-0729111000-9a2cd1c2347fa062b079

0 references

splash10-004i-0900000000-c8095a31ed4b3dbbc646

0 references

splash10-03di-0190000000-330b3c81e4279f2c12b0

0 references

splash10-0002-0900000000-efc5dfd988dedf39f4f8

0 references

splash10-0006-0502193020-497bfad7ba247159ca00

0 references

splash10-004i-0900000000-0b0d4b6dcb7f1fa24e1a

0 references

splash10-014i-0690000000-622497b3104c6082a45d

0 references

splash10-00xr-9350000000-b0cc4636931d2de64d81

0 references

splash10-0002-0900000000-df116b84981cf4a1371a

0 references

splash10-0f6t-0900000000-1c1c39a8880442ea18df

0 references

splash10-0002-0900000000-a115045cfda5ed918bc4

0 references

splash10-0udi-0900000000-d11c32cf4edd5c61cbc1

0 references

splash10-0002-0900000000-983bcc6e878cf78ddda0

0 references

splash10-014i-1890000000-646d209fa1943582a336

0 references

splash10-014i-0690000000-720ed87e98a0d9f1721d

0 references

splash10-0uei-2900000000-501c8856e3516b98773c

0 references

splash10-0f8s-0900000000-70920dcbff18a08f8d3d

0 references

splash10-00e0-2900000000-dd5919e4a742c1089fca

0 references

splash10-056r-9300000000-a78b0b31dd33fe8479a7

0 references

splash10-014i-0590000000-4474e81e4226bb4e1d4c

0 references

splash10-0a59-2900000000-bf63b9b719959b82b543

0 references

splash10-0uea-0900000000-8eb71aa0cc8622f097a2

0 references

HSDB ID

3348

1 reference

Hazardous Substances Data Bank

28 October 2019

LEVODOPA (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

0 references

1 reference

levodopa (English)

ECHA Substance Infocard ID

19 November 2016

100.000.405

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Levodopa (English)

CAS no.: 59-92-7 (English)

1 reference

World Health Organisation international non-proprietary name numeric ID

Levodopa (English)

publication date

17 November 2015

2651

1 reference

https://mednet-communities.net/inn/db/ViewINN.aspx?i=2651

Guide to Pharmacology Ligand ID

3639

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

3639

D02.455.426.559.389.657.166.175.200.480

levodopa (English)

19 November 2016

Levodopa

0 references

0 references

0 references

0 references

D12.125.072.050.685.400.500

0 references

D12.125.072.050.875.130.500

0 references

RxNorm ID

6375

1 reference

levodopa (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0000181

2 references

based on heuristic

inferred from InChIKey

1 reference

L-dopa (English)

19 October 2016

2 references

levodopa (English)

19 November 2016

MedlinePlus drug identifier

a619018

0 references

PatientsLikeMe treatment ID

0 references

0 references

1 reference

levodopa (English)

19 November 2016

0 references

1 reference

1 reference

Immune Epitope Database and Analysis Resource

Levodopa (English)

19 January 2016

1 reference

1 March 2022

0 references

A Dictionary of Biology ID

2476

0 references

Brockhaus Enzyklopädie online ID

0 references

0 references

1 reference

California Proposition 65 list of chemicals

6 January 2020

https://oehha.ca.gov/chemicals/levodopa

DeCS ID

24230

0 references

electronic Essential Medicines List medicine ID

411

0 references

Elhuyar ZTH ID

027365

0 references

Encyclopædia Britannica Online ID

science/levodopa

subject named as

levodopa

0 references

1 reference

28 October 2013

Gran Enciclopèdia Catalana ID

levodopa

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0119241

0 references

Microsoft Academic ID

0 references

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

2VH3 (English)

19 October 2016

1 reference

2ZWE (English)

19 October 2016

1 reference

2ZWG (English)

19 October 2016

1 reference

2ZWF (English)

19 October 2016

1 reference

4EIS (English)

19 October 2016

1 reference

1IVV (English)

19 October 2016

1 reference

6PAH (English)

19 October 2016

1 reference

1RNR (English)

19 October 2016

1 reference

4P6S (English)

19 October 2016

1 reference

3TEG (English)

19 October 2016

1 reference

Treccani's Dizionario di Medicina ID

3TEH (English)

19 October 2016

0 references

dopa

subject named as

DOPA

publication date

2010

0 references

UK Parliament thesaurus ID

418369

subject named as

Levodopa

0 references

UMLS CUI

C0023570

1 reference